Somatostatin versus endoscopic nasal biliary drainage in the prevention of post-ERCP pancreatitis and hyperamylasemia

World Chinese Journal of Digestology

Volumn 20, Issue 25, 2012, Pages 2427-2431

  Guo, Han Bin ^a   Li, Hao Ran ^a   Li, Shao Xiang ^a   Ma, Li ^a   Gong, Li Juan ^a   Cao, Jian Biao ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Endoscopic nasal biliary drainage; Endoscopic retrograde cholangiopancreatography; Hyperamylasemia; Pancreatitis; Somatostatin

Indexed keywords

AMYLASE; PLACEBO; SOMATOSTATIN;

ARTICLE; BILIARY TRACT DRAINAGE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENDOSCOPIC NASAL BILIARY DRAINAGE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HUMAN; HYPERAMYLASEMIA; LENGTH OF STAY; MAJOR CLINICAL STUDY; PANCREATITIS; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

EID: 84922980953     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, Liguory C, Nickl N. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991; 37: 383-393
2. Booth FV, Doerr RJ, Khalafi RS, Luchette FA, Flint LM. Surgical management of complications of endoscopic sphincterotomy with precut papillotomy. Am J Surg 1990; 159: 132-135; discussion 132-135
3. Vandervoort J, Soetikno RM, Tham TC, Wong RC, Ferrari AP, Montes H, Roston AD, Slivka A, Lichtenstein DR, Ruymann FW, Van Dam J, Hughes M, Carr-Locke DL. Risk factors for complications after performance of ERCP. Gastrointest Endosc 2002; 56: 652-656
4. Gan SI, Kozarek RA. Pancreatic endoscopic retrograde cholangiopancreatography (ERCP). Endoscopy 2012; 44: 389-393
5. Sherman S. ERCP and endoscopic sphincterotomyinduced pancreatitis. Am J Gastroenterol 1994; 89: 303-305
6. Choudhary A, Bechtold ML, Arif M, Szary NM, Puli SR, Othman MO, Pais WP, Antillon MR, Roy PK. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc 2011; 73: 275-282
7. Das A, Singh P, Sivak MV, Chak A. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc 2007; 65: 960-968
8. Cooper ST, Slivka A. Incidence, risk factors, and prevention of post-ERCP pancreatitis. Gastroenterol Clin North Am 2007; 36: 259-276, 7-8
9. van Acker GJ, Perides G, Steer ML. Co-localization hypothesis: a mechanism for the intrapancreatic activation of digestive enzymes during the early phases of acute pancreatitis. World J Gastroenterol 2006; 12: 1985-1990
10. Nøjgaard C, Hornum M, Elkjaer M, Hjalmarsson C, Heyries L, Hauge T, Bakkevold K, Andersen PK, Matzen P. Does glyceryl nitrate prevent post-ERCP pancreatitis? A prospective, randomized, doubleblind, placebo-controlled multicenter trial. Gastrointest Endosc 2009; 69: e31-e37
11. Chinese Source.
12. Chinese Source.
13. Chinese Source.
14. Chinese Source.
15. Chinese Source.
16. Chinese Source.
17. Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, Ryan M, Parker H, Frakes JT, Fogel EL, Silverman WB, Dua KS, Aliperti G, Yakshe P, Uzer M, Jones W, Goff J, Lazzell-Pannell L, Rashdan A, Temkit M, Lehman GA. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol 2006; 101: 139-147